Second Sight Medical (NSDQ:EYES) said last week it named John Blake as its new chief financial officer, succeeding Thomas Miller who has held the position since 2014. Before joining Second Sight Medical, Blake acted as finance senior VP at Tyr Pharma, and has held positions with Volcano Corp and BD Biosciences, the company said. Blake worked with […]
NovaBone launches bioactive bone graft substitutes
NovaBone Products added NovaBone IRM and IRM MacroPOR to its portfolio of biologically active bone graft substitutes today. The Jacksonville, Fla.-based company touted its devices as the industry’s most advanced bioactive synthetic bone graft substitutes available for orthopedic applications. The 2 new formulations are highly irrigation resistant and promote osteogenesis and osteoblastic activity, according to […]
NovaBone wins CE Mark for collagen-based dental wound dressings
Bio-active synthetic bone graft company NovaBone said today that it won CE Mark approval in the European Union for its NovaTape and NovaPlug dental wound dressings. The Jacksonville, Fla.-based company said both devices are collagen-based and designed for the management of soft tissue oral wounds and sores, including dental sores, oral ulcers, periodontal surgical wounds, […]
NovaBone wins PMA for MacroForm bone repair device
Bio-active synthetic bone graft company NovaBone said today it won FDA premarket approval for its MacroForm minimally invasive bone repair device. The device is designed to deliver bone marrow aspirate to a graft via an minimally invasive cannula, the Jacksonville, Fla.-based company said. “The MacroForm MIS delivery system builds off the commercial success of the […]
